Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.24 EUR | +2.25% | -3.63% | +23.71% |
09/05 | DIARY-Top Economic Events to July 3 | RE |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 431.71Cr 467.55Cr 39TCr | Sales 2025 * | 425.01Cr 460.29Cr 38TCr | Capitalization | 1.07TCr 1.16TCr 97TCr |
---|---|---|---|---|---|
Net income 2024 * | 149.8Cr 162.24Cr 14TCr | Net income 2025 * | 138.1Cr 149.57Cr 12TCr | EV / Sales 2024 * | 2.49 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.53 x |
P/E ratio 2024 * |
6.99
x | P/E ratio 2025 * |
7.04
x | Employees | 10,845 |
Yield 2024 * |
6.42% | Yield 2025 * |
6.82% | Free-Float | 99.92% |
Latest transcript on Bank of Ireland Group plc
1 day | +2.25% | ||
1 week | -3.63% | ||
Current month | +0.75% | ||
1 month | +7.04% | ||
3 months | +24.16% | ||
6 months | +17.72% | ||
Current year | +23.71% |
Managers | Title | Age | Since |
---|---|---|---|
Myles O’Grady
CEO | Chief Executive Officer | - | 17/22/17 |
Director of Finance/CFO | - | 01/13/01 | |
Ciarán Coyle
COO | Chief Operating Officer | - | 01/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 15/19/15 | |
Patrick Kennedy
CHM | Chairman | 54 | 01/10/01 |
Director of Finance/CFO | - | 01/13/01 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 10.21 | +1.91% | 6 436 |
14/24/14 | 10.02 | +0.60% | 1,472,531 |
13/24/13 | 9.955 | +2.10% | 33,444 |
10/24/10 | 9.75 | -0.96% | 39,941 |
09/24/09 | 9.845 | -7.03% | 229,864 |
Delayed Quote London S.E., May 15, 2024 at 02:01 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.47% | 58TCr | |
+14.32% | 30TCr | |
+17.02% | 25TCr | |
+25.74% | 22TCr | |
+19.57% | 18TCr | |
+23.83% | 17TCr | |
+11.77% | 16TCr | |
+6.22% | 15TCr | |
-15.88% | 13TCr |
- Stock Market
- Equities
- BIRG Stock
- BKIR Stock